A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Clinical trial NCT06257264 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06257264
Sponsor: BeiGene
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Small Cell Lung Cancer Ovarian Cancer Gastric Cancer Hormone-receptor-positive Breast Cancer Hormone Receptor Positive HER-2 Negative Breast Cancer Advanced Solid Tumor Endometrial Cancer Prostate Cancer TNBC - Triple-Negative Breast Cancer GastroEsophageal Cancer Bladder Cancer

Start date: 2024-03-11
Primary completion: 2026-08-31
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.